Growth Metrics

Idexx Laboratories (IDXX) Free Cash Flow (2016 - 2026)

Idexx Laboratories has reported Free Cash Flow over the past 17 years, most recently at $326.3 million for Q4 2025.

  • For Q4 2025, Free Cash Flow rose 115.39% year-over-year to $326.3 million; the TTM value through Dec 2025 reached $1.1 billion, up 30.82%, while the annual FY2025 figure was $1.1 billion, 30.82% up from the prior year.
  • Free Cash Flow for Q4 2025 was $326.3 million at Idexx Laboratories, down from $371.2 million in the prior quarter.
  • Over five years, Free Cash Flow peaked at $371.2 million in Q3 2025 and troughed at $44.3 million in Q4 2022.
  • A 5-year average of $183.4 million and a median of $180.9 million in 2021 define the central range for Free Cash Flow.
  • Biggest five-year swings in Free Cash Flow: skyrocketed 757.07% in 2021 and later tumbled 62.17% in 2022.
  • Year by year, Free Cash Flow stood at $105.1 million in 2021, then tumbled by 57.92% to $44.3 million in 2022, then surged by 391.05% to $217.3 million in 2023, then crashed by 30.28% to $151.5 million in 2024, then surged by 115.39% to $326.3 million in 2025.
  • Business Quant data shows Free Cash Flow for IDXX at $326.3 million in Q4 2025, $371.2 million in Q3 2025, and $132.3 million in Q2 2025.